María Luisa Carcedo, Minister of Health, Consumption and Social Welfare, announced on Thursday that the Interterritorial Council of the National Health System (CISNS) has approved the extension of the financing of glucose monitoring systems by means of sensors (flash type) to all adult patients with type 1 diabetes, which will be effective before December 31, 2020.
The 'flash' system consists of a device that has a sensor that adheres to the skin and that prevents the person from having to be punctured to know their blood glucose. It is estimated that the use of these devices reduces episodes of severe hypoglycaemia by 55 percent, compared to patients who perform control by punctures.
The system already financed for children under 18 since last September 19, but now it will be extended to the rest of affected people. In addition, it had already been agreed to fund groups of adult patients with type 1 diabetes who performed intensive therapy with insulin (multiple daily doses or insulin pump) and required at least six punctures a day.
These patients, as recalled by the minister at the press conference after the CISNS, are those with visual impairment or severe functional limitations, who suffer from repeated hypoglycemia and pregnant women or women who plan a pregnancy. In this case, the deadline to apply the measure ends next June.
53,723 adult patients will benefit, in addition to the 13,250 minors who already have the device financed by the SNS
Now, the CISNS has approved to establish the terms of access to these devices of the rest of adult patients who perform intensive therapy and require, at least, six daily functions. In this way, as reported by Carcedo, before December 31, 2020 the remaining patients will be incorporated. With the incorporation of these groups 53,723 adult patients will benefit, which are added to the 13,250 minors who already have the device financed by the SNS.